The Federal Court of Appeal took the occasion of an appeal of the order of the Patented Medicines Prices Review Board (the “Board”) that required a patentee to share reports on medicines that were no longer under patent, to reaffirm the jurisdiction of the Board. Courts have consistently held that the Board’s jurisdiction is limited...Read More